The Company announced the appointment of new members to its Board of Directors to help guide its next phase of growth and innovation, including ...

Almost a year after two historic approvals, Pfizer is pulling a sickle cell disease treatment from the market, and the ...

Biotech industry leaders added to the Board of Directors, bringing deep expertise in drug discovery, neuroscience clinical development, and ...

The fatality underscores the risks of one-time, genetic treatments for blood disorders like sickle cell and beta thalassemia, including those already marketed by Bluebird Bio and Vertex.

Two senior officers of the Philippine National Police (PNP) were administratively relieved from their posts amid allegations ...

Two illegal mines and a POGO raided recently have been operating for years. Authorities are determining who the “padrinos” are.

The experience zone will allow enterprises to witness AI technologies and identify the optimal generative AI use cases.

Presented additional data from the Phase 1 clinical trial ENTR-601-44-101 and new preclinical data supporting ENTR-601-45 for DMD at 2024 World Muscle Society Annual Congress – – On track to submit gl ...

Pioneers like Alnylam Pharmaceuticals have led the RNA interference field for years. Now, a crop of young biotechs is ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...